Meiqing L. Wu
No. 6 Shuangyong Road
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Haploidentical haematopoietic stem cell transplantation for thalassaemia major: A phase IV, open-label, single-centre trial.
Journal: British journal of haematology
Published: June 15, 2026
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study.
Journal: Experimental hematology & oncology
Published: March 25, 2026
Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical trial.
Journal: Therapeutic advances in hematology
Published: August 07, 2025
Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study.
Journal: American journal of hematology
Published: July 09, 2025
Transforming the treatment of Alpha-Thalassemia: a single-center retrospective study on hematopoietic stem cell transplantation in transfusion-dependent pediatric patients.
Journal: Annals of hematology
Published: May 28, 2025
Prediction model for cytomegalovirus infection following hematopoietic stem cell transplantation in patients with β-thalassemia major.
Journal: SAGE open medicine
Published: March 24, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.
Journal: Leukemia
Published: January 20, 2025
Lactic acidosis in hemophagocytic syndrome: diagnostic and therapeutic challenges in the intensive care unit-a case series.
Journal: Journal of medical case reports
Published: November 25, 2024
Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial.
Journal: The Lancet. Haematology
Published: September 19, 2024
Risk Factors and Prognostic Markers for Posterior Reversible Encephalopathy Syndrome in Patients With Thalassemia Major After Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: American journal of hematology
Published: August 23, 2024
Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 13, 2024
Last Updated: 09/26/2026